推荐产品
检测方案
99%
形式
rod
制造商/商品名称
Goodfellow 843-270-37
电阻率
57 μΩ-cm, 20°C
长度 × 直径
50 mm × 12.5 mm
bp
3338 °C (lit.)
mp
1522 °C (lit.)
密度
4.469 g/mL at 25 °C (lit.)
SMILES字符串
[Y]
InChI
1S/Y
InChI key
VWQVUPCCIRVNHF-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
For updated SDS information please visit www.goodfellow.com.
法律信息
Product of Goodfellow
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
Aki Aoyama et al.
Molecular cancer therapeutics, 13(12), 2978-2990 (2014-10-15)
Tivantinib (ARQ197) was first reported as a highly selective inhibitor of c-MET and is currently being investigated in a phase III clinical trial. However, as recently reported by us and another group, tivantinib showed cytotoxic activity independent of cellular c-MET
Yukiko Ishihara et al.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 31(8), 781-785 (2015-08-11)
With a view to enhance the sensitivity of analytical instruments used in the measurement of trace elements contained in a single cell, we have now equipped the previously reported micro-droplet injection system (M-DIS) with a desolvation system. This modified M-DIS
Xue Wang et al.
Journal of nanoscience and nanotechnology, 14(5), 3910-3913 (2014-04-17)
Nd3+ doped alpha-NaYF4 nanocrystals with size of about 15 nm were successfully synthesized through hydrothermal method. Nearly pure near-infrared to near-infrared (NIR-to-NIR) luminescence can be realized. Moreover, the excitation and the emission at 880 and 1060 nm, respectively, are away
G Scholz et al.
Dalton transactions (Cambridge, England : 2003), 44(30), 13522-13529 (2015-07-03)
Nanoscopic yttrium acetate fluorides Y(CH(3)COO)(3-z)F(z) and yttrium oxide fluorides YO(3-z)/(2)F(z )were prepared with tunable Y/F molar ratios via the fluorolytic sol-gel route. All samples were characterized by X-ray diffraction, elemental analysis and thermal analysis. In addition, local structures of all
Ryan Hickey et al.
International journal of radiation oncology, biology, physics, 88(5), 1025-1031 (2014-03-26)
Radiosensitizing chemotherapy improves the outcomes in comparison with radiation alone for gastrointestinal cancers. The delivery of radiation therapy with yttrium90 ((90)Y) radioembolization, in combination with the radiosensitizing chemotherapeutic agent capecitabine, provides the opportunity to enhance the effects of radiation on
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门